Alicin F. Roop, PA-C

Alicin Roop practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Alicin Roop's NPI, 1366716540, was assigned on March 6, 2012. Alicin Roop holds Florida license PA9111905.

Alicin Roop's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Alicin Roop's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Alicin Roop to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Alicin Roop practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Alicin Roop's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Dmand AI has Alicin Roop's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists fibromyalgia and chronic pain and fluid and electrolyte imbalances among the conditions Alicin Roop treats.

CMS data shows 585 Medicare services from Alicin Roop across 4 procedure codes in 2024, for 217 Medicare patients. Medicare paid $31,311 for them.

CMS counts 217 Medicare patients who saw Alicin Roop in 2024. The largest group is 65 to 74, with 110 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 5% are also on Medicaid. Their average risk score is 3.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Alicin Roop's median patient age at 71, with 55% women.

In 2024, Alicin Roop wrote 139 Medicare Part D claims for 55 patients. 95% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $653 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Alicin Roop for performance year 2024, reported as part of a group. Alicin Roop accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Alicin Roop as offering telehealth.

CMS Open Payments shows 13 general payments to Alicin Roop from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 80% of the total. Fresenius Kabi USA, LLC paid the most, $243.